HC Wainwright & Co. Maintains Buy on Dynavax Technologies, Raises Price Target to $28
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Edward White maintains a 'Buy' rating on Dynavax Technologies (NASDAQ:DVAX) and raises the price target from $27 to $28.
November 03, 2023 | 10:59 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Dynavax Technologies' price target has been raised from $27 to $28 by HC Wainwright & Co. The firm maintains a 'Buy' rating on the stock.
The raised price target and maintained 'Buy' rating by HC Wainwright & Co. indicates a positive outlook for Dynavax Technologies. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100